Nat. Rev. Nephrol. doi: /nrneph

Slides:



Advertisements
Similar presentations
Date of download: 7/11/2016 From: Cost-Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease Ann Intern Med. 2013;159(6):
Advertisements

R1. 이용석 / modulator pf. 임천규. Introduction Autosomal dominant polycystic kidney disease (ADPKD) is characterized by gradual cyst enlargement over a period.
November 3, 2012 N Engl J Med DOI: /NEJMoa
Illustration of the origin of tubular cysts
The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease  Ryo Matsuura, Kenjiro.
Improved prognosis of diabetic nephropathy in type 1 diabetes
Characteristics IgAN (n=28) ADPKD (n=37) Male (percentage) 21 (75.0)
Renal Parenchymal Hypoxia, Hypoxia Response and the Progression of Chronic Kidney Disease Am J Nephrol 2008;28:998– DOI: / © 2008.
Ann Intern Med. 2013;159(6): doi: / Figure Legend:
Urine and Plasma Osmolality in Patients with Autosomal Dominant Polycystic Kidney Disease: Reliable Indicators of Vasopressin Activity and Disease Prognosis?
Current status of end-stage renal disease care in India and Pakistan
Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.
Figure 4 Interplay between acute kidney injury (AKI),
Figure 4 The theoretical contribution of genetic and
Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Mechanisms of kidney injury in the setting of obesity
Figure 2 Physiological changes in the renal system in pregnancy
Figure 2 Proinflammatory mechanisms in CKD
Research at the Intersection of Biomarkers and Causal Inference
Nat. Rev. Nephrol. doi: /nrneph
Figure 7 The efficacy of phosphate-binder therapy
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.
Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc 
Figure 2 The network of chronic diseases and their mutual influences
Section 2: AKI Definition
Figure 1 The burden of chronic kidney disease (CKD)
Figure 3 Societal costs for the care of patients with chronic kidney disease in the UK Figure 3 | Societal costs for the care of patients with chronic.
Figure 2 Glomerular pathology in mice and humans with diabetic nephropathy Figure 2 | Glomerular pathology in mice and humans with diabetic nephropathy.
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Acute kidney injury and chronic kidney disease
Figure 2 The continuum of acute kidney injury (AKI),
Current status of end-stage renal disease care in India and Pakistan
Figure 4 Model of changes in the serum levels
A Decade After the KDOQI CKD Guidelines
Robert W. Schrier, Kimberly K. McFann, Ann M. Johnson 
Jason T. Lee, MD, Vinit N. Varu, MD, Kenneth Tran, BS, Ronald L
Matei Neagu, PhD, Daniel Coca, PhD, Albert C.M. Ong, DM 
Nat. Rev. Nephrol. doi: /nrneph
Prehypertension and chronic kidney disease: the ox or the plow?
John P. Middleton, Patrick H. Pun  Kidney International 
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph
Susumu Takahashi, Kazuyoshi Okada, Mitsuru Yanai  Kidney International 
Figure 3 Hypothetical trajectories of acute kidney disease (AKD)
Figure 5 The nephron-centric model of renal transplant fibrosis based on the injury-related molecular events observed in biopsy samples in the first year.
Figure 6 Hypothetical effect of starting therapy for autosomal
Meeting the challenges of the new K/DOQI guidelines
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Volume 82, Issue 10, Pages (November 2012)
Volume 93, Issue 3, Pages (March 2018)
Nat. Rev. Nephrol. doi: /nrneph
Volume 59, Issue 5, Pages (May 2001)
Volume 65, Issue 2, Pages (February 2004)
Volume 76, Issue 6, Pages (September 2009)
Volume 79, Issue 2, Pages (January 2011)
Nowak et al. Am J Nephrol 2016;44: (DOI: / )
Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske 
Copyright © 2013 Elsevier Inc. All rights reserved.
Citrate therapy for polycystic kidney disease in rats
Improved prognosis of diabetic nephropathy in type 1 diabetes
Blood lead and chronic kidney disease in the general United States population: Results from NHANES III  Paul Muntner, Jiang He, Suma Vupputuri, Josef.
Volume 80, Issue 10, Pages (November 2011)
Volume 58, Issue 6, Pages (December 2000)
Off-pump bilateral skeletonized internal thoracic artery grafting in patients with chronic kidney disease  Takeshi Kinoshita, MD, PhD, Tohru Asai, MD,
Ann M. O'Hare, MA, MD  American Journal of Kidney Diseases 
Nat. Rev. Nephrol. doi: /nrneph
Volume 67, Issue 4, Pages (April 2005)
Figure 1 Relationships between genetic variants, quantitative traits and diseases Figure 1 | Relationships between genetic variants, quantitative traits.
Volume 64, Issue 3, Pages (September 2003)
Presentation transcript:

Nat. Rev. Nephrol. doi:10.1038/nrneph.2016.135 Figure 5 Hypothetical inverse relationship between total kidney volume (TKV) and glomerular filtration rate (GFR) in patients with autosomal dominant polycystic kidney disease (ADPKD) Figure 5 | Hypothetical inverse relationship between total kidney volume (TKV) and glomerular filtration rate (GFR) in patients with autosomal dominant polycystic kidney disease (ADPKD). Increasing rates of TKV growth are shown by exponential-like curves. The corresponding GFR curves are based on the assumption that, in the absence of modifying factors, GFR decline is linked to the progressive increase in TKV in patients with ADPKD. At the age of 18 years, TKV is assumed to be 400 ml53 and GFR 120 ml/min/1.73 m2. GFR in each succeeding year is determined from the equation GFR = (GFRt-1) – (TKVt /400) where t is age and t-1 is age minus 1 year. GFR decline is determined by the fractional increase in TKV (TKVt /400). The model illustrates the initial decades during which GFR remains within normal limits shown by values above the dashed horizontal line depicting the lower limit of chronic kidney disease stage 1; the escalating rate of GFR decline over time; and the inverse relationship between GFR decline and the formation and expansion of cysts as measured by TKV. a | For a TKV increase of 5% per year, GFR reaches 0.0 ml/min/1.73 m2 at 57 years of age. b | For a TKV increase of 7% per year GFR reaches 0.0 ml/min/1.73 m2 at 50 years of age. c | For a TKV increase of 10% per year GFR reaches 0.0 ml/min/1.73 m2 at 43 years of age. Grantham, J. J. & Torres, V. E. (2016) The importance of total kidney volume in evaluating progression of polycystic kidney disease Nat. Rev. Nephrol. doi:10.1038/nrneph.2016.135